Treatment of Wounds With a New Adhesive Foam Dressing

February 14, 2018 updated by: Smith & Nephew, Inc.

A Prospective, Open Study to Evaluate the Clinical Performance of a New Adhesive Foam Dressing in the Treatment of Partial Thickness Burns, Acute and Chronic Wounds.

This study will look at whether ELECT, a new adhesive foam dressing, can offer an alternative to traditional wound care methods.

Patients will be treated with ELECT for 14 days. Data relating to wound healing, the performance of the dressing and the opinion of the doctor will be collected.

The hypothesis of this study is that the ELECT foam adhesive dressing is 'fit for purpose' and will be effective at treating a variety of wounds.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Durban, South Africa, 4058
        • Inkosi Albert Luthuli Central Hospital (IALCH)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

INCLUSION CRITERIA

  1. Participants must be ≥1 years old
  2. Males and females (females must not be pregnant and must use contraception if of child bearing potential)
  3. Participant must have a partial thickness burn, acute or chronic wound that would benefit from the application of an advanced wound dressing to help facilitate moist wound healing
  4. Presence of a suitable wound which can be treated with the available sizes of the ELECT Adhesive Foam Dressing (7.5cm x 7.5cm, 12.5cm x 12.5cm, 15cm x 15cm and 17.5cm x 17.5cm)
  5. Participant is under the direct observation of the investigator for the duration of the study (i.e the participant's wound must not be treated by another clinician throughout the duration of the study).
  6. The participant or the participant's legal representative is able to understand and is willing to consent to the study.

EXCLUSION CRITERIA

  1. Participants with a known history of poor compliance with treatment (including if the participant has a known , diagnosed emotional or neurological condition such as mental disorders/illnesses, mental retardation, drug or alcohol abuse, that would pre-empt their ability to understand and consent)
  2. Participants who are unable to understand the aims and objectives of the study.
  3. Participant is a prisoner.
  4. Participants with a known sensitivity to any of the constituents of the evaluation products, including polyester, polyurethane, and acrylic adhesive
  5. Participants with facial wounds as the reference wound
  6. Participants with confirmed or suspected clinically infected reference wounds (unless wounds are being treated per standard protocol for wound infection)
  7. Participant is likely to undergo foreseeable definitive surgery within 2 weeks from screening
  8. Participants where a reference wound cannot be treated in isolation from other wounds
  9. Participants who have participated in this evaluation previously and closed/100% healed, or have been withdrawn from the study, or any previous studies
  10. Participant who are employees of Smith & Nephew group companies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ELECT
Adhesive Foam Dressing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound progression, (percentage change in area) using a wound imaging measurement and wound documentation system
Time Frame: 14 days
using a wound imaging, measurement and wound documentation system
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage change in wound depth
Time Frame: 14 days
14 days
Percentage change in wound volume
Time Frame: 14 days
14 days
Duration of dressing wear
Time Frame: 14 days
14 days
The proportion of wounds that have 100% healed or closed by secondary intention.
Time Frame: 14 days
14 days
Assessment of exudate type and amount
Time Frame: 14 days
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
14 days
Assessment of Condition of the peri-wound skin
Time Frame: 14 days
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
14 days
Assessment of the amount of tissue and skin colour
Time Frame: 14 days
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
14 days
Assessment of infection/clinical signs of infection
Time Frame: 14 days
Assessment using Normal Clinical practice
14 days
Pain on application and removal of dressing (using a Visual Analogue Scale (VAS) or FLACC scale)
Time Frame: 14 days
14 days
Reason for dressing change
Time Frame: 14 days
14 days
Ease of application and removal of the ELECT dressing using the visual analogue scale
Time Frame: 14 days
14 days
Overall clinician acceptability with the new dressing
Time Frame: 14 days
Measured using a questionnaire
14 days
Clinician acceptability with dressing performance parameters
Time Frame: 14 days
Measured using a questionnaire
14 days
Safety in use - all adverse events that occur during the study will be recorded
Time Frame: 14 days
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alessandro Andreone, MD, Inkosi Albert Luthuli Central Hospital (IALCH)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

June 14, 2016

First Submitted That Met QC Criteria

June 16, 2016

First Posted (Estimate)

June 21, 2016

Study Record Updates

Last Update Posted (Actual)

February 19, 2018

Last Update Submitted That Met QC Criteria

February 14, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CE053ELE

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds and Injuries

Clinical Trials on ELECT

Subscribe